Crystal Crop Protection IPO GMP Signals 6.62% Listing Gain
Key highlights
- Crystal Crop Protection's latest reported ₹18 GMP implies a ₹290 price, or a 6.62% premium to the ₹272 upper band.
- The ₹455.48 crore IPO includes a fresh issue of about ₹354.77 crore and an offer for sale of about ₹100.71 crore.
- The minimum retail application is 55 shares, costing ₹14,960 at the ₹272 upper price band.
- Crystal Crop Protection reported ₹952.02 crore of total borrowings as of June 30, 2026.
powered by IRIS

Crystal Crop Protection Ltd's IPO grey market premium of ₹18 implies a ₹290 listing price, indicating a potential 6.62% gain over the ₹272 upper issue price ahead of the proposed November 26, 2026 listing. This is an unofficial market indication, not a forecast of the opening price or investor returns.
What does the Crystal Crop Protection IPO GMP indicate?
Crystal Crop Protection's latest reported grey market premium of ₹18 points to an implied listing price of ₹290 per share, based on the ₹272 upper end of the price band. That translates into a 6.62% premium to the issue price. Another reported quote placed the GMP at ₹19, which would imply ₹291 and a potential gain of 6.99%.
The available GMP trend shows that sentiment has shifted over recent sessions. The implied price was ₹285, or 4.78% above the issue price, on November 16, then moved to ₹291, or 6.99%, on November 17. It was reported at ₹290 and 6.62% on November 18. These movements show why grey-market pricing should be treated as a changing, unofficial reference rather than a firm estimate.
What are the Crystal Crop Protection IPO terms?
Crystal Crop Protection is offering shares in a ₹259 to ₹272 price band, with the total issue valued at about ₹455.48 crore at the upper band. The public issue opened on November 18, 2026 and closes on November 20, 2026. Retail investors need to apply for at least 55 shares, requiring ₹14,960 at the upper price.
The offer includes a fresh issue of about ₹354.77 crore and an offer for sale of 3,702,694 shares valued at about ₹100.71 crore at the upper band. The shares have a face value of ₹10 and are proposed to list on the BSE and NSE. Allotment is expected to be finalised on November 23, followed by the tentative listing on November 26.
Why is Crystal Crop Protection raising fresh capital?
Crystal Crop Protection plans to use part of its IPO proceeds to repay debt and fund strategic growth initiatives. A reported ₹247.94 crore of the proceeds is earmarked for repayment of existing borrowings, making deleveraging a central use of the fresh issue.
The company had total borrowings of ₹952.02 crore as of June 30, 2026. Some funds are also intended for unidentified acquisitions and strategic initiatives. That creates an area for investors to monitor because the specific deployment and outcome of those initiatives are not identified in the available discussion.
Got a follow-up? Ask IRIS
What business and financial figures are being discussed?
Crystal Crop Protection operates across agrochemicals, crop nutrition, natural solutions and seeds, with products sold under more than 174 brands. Its distribution network includes over 13,000 distributors and 36 distribution centres. The company also has export exposure to Bangladesh, Nepal, Africa and Asia.
For the period ended June 30, 2026, Crystal Crop Protection reported total income of ₹1,209.21 crore, profit after tax of ₹135.78 crore and EBITDA of ₹241.78 crore. Net worth stood at ₹2,039.76 crore. Social-media discussion also cited revenue growth of 16% and profit after tax growth of 22% between FY25 and FY26, while highlighting the importance of debt reduction and execution of future strategic plans.
Is the Crystal Crop Protection IPO valuation being debated?
Crystal Crop Protection's valuation is a key part of the discussion because its cited P/E ratio of 28.19 is above Kaveri Seed at 12.13 times and Dhanuka Agritech at 14.38 times. It is below Sumitomo Chemical India at 31.20 times, while Bayer CropScience was cited at 22.73 times. Another discussion placed the issue valuation above the RHP peer average of 20.07 times.
These comparisons do not establish whether the issue will list at a premium or discount. They indicate that investors are weighing the company's reported growth, integrated model and distribution reach against the debt-repayment requirement, the allocation for unidentified initiatives and the valuation relative to selected peers.
Conclusion
The available grey-market quotes indicate moderate positive sentiment around Crystal Crop Protection, with the latest ₹18 GMP implying a ₹290 price and a 6.62% potential gain at the ₹272 upper band. However, the GMP has ranged across recent reports, and it remains an unofficial indicator rather than evidence of the actual listing price.
Investors will next watch the closing of the issue on November 20, the expected allotment finalisation on November 23 and the proposed BSE and NSE listing on November 26. They will also track how Crystal Crop Protection uses fresh-issue proceeds for debt repayment and the subsequent clarity around strategic initiatives and acquisitions.


